4//SEC Filing
David Matthew T 4
Accession 0001213900-21-002050
CIK 0001410098other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 8:00 PM ET
Size
9.5 KB
Accession
0001213900-21-002050
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
David Matthew T
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2021-01-11+80,000→ 80,000 totalExercise: $8.32Exp: 2031-01-11→ Common Stock (80,000 underlying)
Holdings
- 1,150
Common Stock
- 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $4.08Exp: 2030-05-11→ Common Stock (125,000 underlying) - 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.63Exp: 2030-05-11→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
- [F2]These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
Documents
Issuer
CorMedix Inc.
CIK 0001410098
Entity typeother
Related Parties
1- filerCIK 0001811612
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 8:00 PM ET
- Size
- 9.5 KB